Publications by authors named "N Swietek"
Background: The incidence of papillary thyroid microcarcinomas (PMCs) has increased sharply and therefore the lack of consensus for treatment has become a clinical dilemma. Our aim was to evaluate a less-radical approach.
Methods: This study includes 1,391 patients with PMC treated at a single surgical referral center in the endemic goiter area in Austria.
Introduction: Surgical site infections after thyroid surgery are mostly superficial and can be well treated. Streptococcal mediastinitis in contrast is a rare but life-threatening complication.
Case Report: A 57-year-old female patient experienced septic fever, increase of inflammation parameters and erythema 2 days after thyroid surgery for Graves' disease.
Salvaging ruins: reverting blind retinas into functional visual sensors.
Methods Mol Biol
December 2014
Blindness is one of the most devastating conditions affecting the quality of life. Hereditary degenerative diseases, such as retinitis pigmentosa, are characterized by the progressive loss of photoreceptors, leading to complete blindness. No treatment is known, the current state-of-the-art of restoring vision are implanted electrode arrays.
View Article and Find Full Text PDFArticle Synopsis
- The study evaluated the effectiveness of a 24-core template-guided transperineal biopsy (TPB) for detecting prostate cancer in men who had previously negative biopsies.
- The research involved 50 men with specific criteria and found that prostate cancer was detected in 48% of them, with some cases being clinically insignificant.
- The TPB procedure was deemed safe, with minimal complications reported, suggesting it as a viable option for men with prior negative results.
Objective: To evaluate the frequency of bladder outlet obstruction (BOO) and detrusor overactivity (DO) in patients with castration-resistant prostate cancer (CRPC) and lower urinary tract symptoms (LUTS).
Patients And Methods: Our prospective urodynamics database was queried. Inclusion criteria were CRPC and an International Prostate Symptom Score (IPSS) ≥ 20.